Modelling Scientist Opportunity at Novo Nordisk A/S About the department The Quantitative Clinical Pharmacology (QCP) department supports the entire Novo Nordisk development portfolio with model-based analyses from first in human trials to registration. We are a team of dedicated modelling scientists with an important role in the development of new drugs at Novo Nordisk as responsible for designing, analysing, interpreting, communicating and reporting quantitative clinical pharmacology information at all stages of clinical drug development.
The job As Modelling Scientist you will have an important role in the development of new drugs at Novo Nordisk. You will be part of multidisciplinary project teams where you will be responsible for developing modelling analysis plans for the project and follow them to completion. The position is located in Søborg, Denmark Qualifications You hold a university degree, e.g. statistics, engineering, pharmacy or other, preferably complemented by a PhD. You must have in depth understanding of pharmacokinetics/pharmacodynamics, statistical methodology, and data interpretation as well as hands-on experience performing model-based analyses using S-PLUS/R and/or NONMEM. You are innovative with a high degree of independence, result and quality oriented, and thrive in a continuously changing environment with tight deadlines. You appreciate an informal atmosphere and act as a dedicated team player. As your colleagues will have different academic backgrounds, good presentation, communication and negotiation skills are essential. You are fluent in English both orally and written. At Novo Nordisk you will work with specialists from around the world. Our ambitious teams work toward developing the next generation of care. As a growing organisation, we offer unique possibilities for personal and professional development, as well as a chance to work alongside the best in the field. Contact For further information, please contact Henrik Agersø at +45 3079 3522 Apply at: http://www.novonordisk.com/careers/job_section/jp.asp?jobid=26999BR&joblng=uk&jobcnt=Denmark&type=1a Deadline 31 January 2015. _____________________________________________________________________________ Henrik Agersø, DVM, PhD Director and Head of Quantitative Clinical Pharmacology Global Development Novo Nordisk A/S Vandtårnsvej 108-110 DK-2860 Søborg Denmark +45 4444 8888 (phone) +45 3079 3522 (mobile) [email protected] www.novonordisk.com<http://www.novonordisk.com> Facebook<http://www.facebook.com/novonordisk> | Twitter<http://www.twitter.com/novonordisk> | LinkedIn<http://www.linkedin.com/company/novo-nordisk> | Youtube<http://www.Youtube.com/novonordisk> | Pinterest<http://www.pinterest.com/novonordisk> Changing the way we look at diabetes A new DAWN for people with diabetes? Click here to read more<http://www.dawnstudy.com/> This e-mail (including any attachments) is intended for the addressee(s) stated above only and may contain confidential information protected by law. You are hereby notified that any unauthorized reading, disclosure, copying or distribution of this e-mail or use of information contained herein is strictly prohibited and may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete it immediately hereafter. Thank you.
